Microbiota-based therapies for Clostridium difficile and antibiotic-resistant enteric infections Journal Article


Authors: Lewis, B. B.; Pamer, E. G.
Article Title: Microbiota-based therapies for Clostridium difficile and antibiotic-resistant enteric infections
Abstract: Bacterial pathogens are increasingly antibiotic resistant, and development of clinically effective antibiotics is lagging. Curing infections increasingly requires antimicrobials that are broader spectrum, more toxic, and more expensive, and mortality attributable to antibiotic-resistant pathogens is rising. The commensal microbiota, comprising microbes that colonize the mammalian gastrointestinal tract, can provide high levels of resistance to infection, and the contributions of specific bacterial species to resistance are being discovered and characterized. Microbiota-mediated mechanisms of colonization resistance and pathogen clearance include bactericidal activity, nutrient depletion, immune activation, and manipulation of the gut's chemical environment. Current research is focusing on development of microbiota-based therapies to reduce intestinal colonization with antibiotic-resistant pathogens, with the goal of reducing pathogen transmission and systemic dissemination. Copyright © 2017 by Annual Reviews.All rights reserved.
Keywords: antibiotic resistance; commensal; microbiota; microbiome; mucosal immunity
Journal Title: Annual Review of Microbiology
Volume: 71
ISSN: 0066-4227
Publisher: Annual Reviews  
Date Published: 2017-09-01
Start Page: 157
End Page: 178
Language: English
DOI: 10.1146/annurev-micro-090816-093549
PROVIDER: scopus
PUBMED: 28617651
DOI/URL:
Notes: Article -- Export Date: 2 October 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eric Pamer
    283 Pamer
  2. Brittany   Lewis
    6 Lewis